WeVote
Log In

Bill

Bill

SB 1591

Medical marijuana; limiting certain THC amounts in certain products and packages. Effective date.

2026 Regular Session Introduced by Paul Rosino

Oklahoma bill caps THC concentrations in specific medical marijuana products to standardize potency and enhance consumer safety through regulated packaging limits.

Second Reading referred to Health and Human Services
0
WeVote Research Nonpartisan
Bill Summary · SB 1591

Legislative bill overview

SB 1591 establishes limits on THC (tetrahydrocannabinol) concentrations in certain medical marijuana products and packages in Oklahoma. The bill specifies maximum allowable THC amounts for particular product categories and sets an effective date for these restrictions to take effect.

Why is this important

THC potency regulations directly affect patient access to medical treatments, product safety standardization, and market compliance for dispensaries. These limits influence dosing consistency, potential health outcomes for medical users, and the competitive landscape of Oklahoma's medical cannabis industry.

Potential points of contention

  • Patient access concerns: Limiting THC concentrations may restrict treatment options for patients requiring higher-potency products for severe conditions, potentially forcing them to consume larger quantities or switch medications
  • Industry impact: Dispensaries and manufacturers holding existing high-THC inventory could face significant financial losses or forced product reformulation if limits are retroactively applied
  • Definitional ambiguity: The bill's specific THC thresholds and which product categories are affected remain unclear from the bill title alone, potentially creating enforcement inconsistencies or unintended regulatory gaps

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.